Congresswoman Diana DeGette

Representing the First District of Colorado
Twitter icon
Facebook icon
YouTube icon
Instagram icon

Press Releases

Apr 18, 2019

DENVER, CO – U.S. Rep. Diana DeGette (D-CO) said today it’s “unacceptable” that the future state of Colorado’s economy lies in the hands of one person.

Apr 18, 2019

WASHINGTON, D.C. – A trio of senior U.S. lawmakers, including Rep.

Apr 18, 2019

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) released the following statement on the release of Special Counsel Robert Mueller’s report:

Apr 11, 2019

WASHINGTON, D.C. – Reps. Diana DeGette (D-CO) and Bill Johnson (R-OH) introduced the Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians (HELLPP) Act, yesterday. The bipartisan legislation will improve patient access to podiatrists in Medicaid and improve care for patients with diabetes who need therapeutic shoes via Medicare. 

Apr 10, 2019
Chair of key House oversight panel blasts makers of insulin for ‘band-aid approach’ to bringing down cost of the drug. ‘This is not optional. It is going to happen,’ DeGette tells execs at hearing Wednesday.

WASHINGTON, D.C. – “The system is broken,” U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s currently investigating the rising cost of insulin, told a panel of drug makers and pharmacy executives who were summoned to appear before Congress today to explain why the cost of the life-saving drug has continued to rise in recent years.

Apr 5, 2019

WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO) and Jackie Speier (D-CA) introduced legislation today to overhaul the U.S. military’s policy on providing servicemembers and their families with family-planning counseling services and coverage for contraceptives.

Apr 2, 2019
U.S. Rep. Diana DeGette, chair of the House oversight panel investigating cost of the drug, announced today

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO), chair of the House oversight panel that’s investigating the skyrocketing cost of insulin, announced today that all three U.S. manufacturers of insulin will be appearing before Congress next week.

Apr 2, 2019

WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO), Mark DeSaulnier (D-CA), Zoe Lofgren (D-CA) and Jamie Raskin (D-MD) introduced a resolution today to recognize the vital role that local journalists play in promoting good governance and accountability.

Apr 1, 2019
Legislation seeks to make permanent a new FDA fast-track approval process for generic forms of insulin

WASHINGTON, D.C. – A bipartisan group of lawmakers introduced legislation today seeking to bring down the cost of certain biologic drugs, such as insulin, by making it easier for drug makers to get generic versions of those drugs approved by the Food and Drug Administration.

Apr 1, 2019

WASHINGTON, D.C. – U.S. Rep. Diana DeGette (D-CO) introduced legislation today that would prevent the federal government from enforcing its prohibition on marijuana in states, such as Colorado, where it is legal for residents to possess and use the drug.